Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway

Li,Xin-Xiang; Huang,Li-Yong; Peng,Jun-Jie; Liang,Lei; Shi,De-Bing; Zheng,Hong-Tu; Cai,San-Jun

doi:10.3892/ijo.2014.2430

Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway

Authors:
- Xin-Xiang Li
- Li-Yong Huang
- Jun-Jie Peng
- Lei Liang
- De-Bing Shi
- Hong-Tu Zheng
- San-Jun Cai
View Affiliations

Affiliations: Department of Colorectal Surgery, Fudan University Shanghai Cancer Center and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China
Published online on: May 9, 2014 https://doi.org/10.3892/ijo.2014.2430
Pages: 611-618

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Klotho (KL) was originally characterized as an aging suppressor gene, and has been identified as a tumor suppressor gene in a variety of cancers including colon cancer. However, the potential role and molecular events for KL in colon cancer remain unclear. The present study aimed to investigate the expression of KL in human colon cancer by immunohistochemistry, and to analyze the correlation between KL expression and clinicopathological characteristics of patients with colon cancer. Functional analysis after lentivirus-mediated gain of KL expression was used to assess the tumor growth and invasion in colon cancer cells in vitro and in vivo. The rate of KL expression was significantly decreased in cancer tissues compared with that in adjacent non-cancer tissues (ANCT) (60.3 vs.77.9%, P=0.022), and KL expression was negatively associated with Dukes staging (P=0.034) and depth of tumor invasion (P=0.008). Overexpression of KL in vitro inhibited cell proliferative activities and invasive potential in colon cancer cells, companied with decreased expression of p-IGF1R, p-PI3K, p-AKT, PCNA and MMP-2. In addition, the tumor volumes in the HT-29 subcutaneous tumor model treated with lentivirus‑mediated KL vector (Lv-KL) was significantly smaller than those of the negative control (NC) group (P<0.01). Taken together, our findings indicate that the expression of KL is downregulated in human colon caner and correlates with tumor invasion and Dukes staging, while overexpression of KL suppresses growth and invasion through inhibition of IGF1R-mediated PI3K/AKT pathway in colon cancer cells, suggesting that KL may serve as a potential therapeutic target for the treatment of colon cancer.

View Figures

View References

1	Antonic V, Stojadinovic A, Kester KE, et al: Significance of infectious agents in colorectal cancer development. J Cancer. 4:227–240. 2013. View Article : Google Scholar
2	Young PE and Womeldorph CM: Colonoscopy for colorectal cancer screening. J Cancer. 4:217–226. 2013. View Article : Google Scholar : PubMed/NCBI
3	Kuro-o M: Klotho as a regulator of oxidative stress and senescence. Biol Chem. 38:233–241. 2008.
4	Xie B, Chen J, Liu B, et al: Klotho acts as a tumor suppressor in cancers. Pathol Oncol Res. 19:611–617. 2013. View Article : Google Scholar : PubMed/NCBI
5	Wang L, Wang X, Wang X, et al: Klotho is silenced through promoter hypermethylation in gastric cancer. Am J Cancer Res. 1:111–119. 2011.PubMed/NCBI
6	Pan J, Zhong J, Gan LH, et al: Klotho, an anti-senescence related gene, is frequently inactivated through promoter hypermethylation in colorectal cancer. Tumour Biol. 32:729–735. 2011. View Article : Google Scholar : PubMed/NCBI
7	Rubinek T, Shulman M, Israeli S, et al: Epigenetic silencing of the tumor suppressor klotho in human breast cancer. Breast Cancer Res Treat. 133:649–657. 2012. View Article : Google Scholar : PubMed/NCBI
8	Usuda J, Ichinose S, Ishizumi T, et al: Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery. Lung Cancer. 74:332–337. 2011. View Article : Google Scholar
9	Xie B, Zhou J, Yuan L, et al: Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma. Hum Pathol. 44:795–801. 2013. View Article : Google Scholar : PubMed/NCBI
10	Doi S, Zou Y, Togao O, et al: Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 286:8655–8665. 2011. View Article : Google Scholar : PubMed/NCBI
11	Camilli TC, Xu M, O’Connell MP, et al: Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility. Pigment Cell Melanoma Res. 24:175–186. 2011. View Article : Google Scholar : PubMed/NCBI
12	Abramovitz L, Rubinek T, Ligumsky H, et al: KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer. Clin Cancer Res. 17:4254–4266. 2011. View Article : Google Scholar : PubMed/NCBI
13	Chen B, Ma X, Liu S, et al: Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner. Cancer Biol Ther. 13:1221–1228. 2012. View Article : Google Scholar : PubMed/NCBI
14	Chen B, Wang X, Zhao W, et al: Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549. J Exp Clin Cancer Res. 29:992010. View Article : Google Scholar : PubMed/NCBI
15	Chang B, Kim J, Jeong D, et al: Klotho inhibits the capacity of cell migration and invasion in cervical cancer. Oncol Rep. 28:1022–1028. 2012.PubMed/NCBI
16	Lu L, Katsaros D, Wiley A, et al: Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Cancer Invest. 26:185–192. 2008. View Article : Google Scholar : PubMed/NCBI
17	Poh W, Wong W, Ong H, et al: Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma. Mol Cancer. 11:142012. View Article : Google Scholar : PubMed/NCBI
18	Hanahan D and Weinberg RA: The hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
19	Kuro-o M: Klotho in health and disease. Curr Opin Nephrol Hypertens. 21:362–368. 2012. View Article : Google Scholar
20	Yahata K, Mori K, Arai H, et al: Molecular cloning and expression of a novel klotho-related protein. J Mol Med (Berl). 78:389–394. 2000. View Article : Google Scholar : PubMed/NCBI
21	Usuda J, Ichinose S, Ishizumi T, et al: Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung. Lung Cancer. 72:355–359. 2011. View Article : Google Scholar : PubMed/NCBI
22	Dërmaku-Sopjani M, Kolgeci S, Abazi S, et al: Significance of the anti-aging protein Klotho. Mol Membr Biol. 30:369–385. 2013.
23	Shu G, Xie B, Ren F, et al: Restoration of klotho expression induces apoptosis and autophagy in hepatocellular carcinoma cells. Cell Oncol (Dordr). 36:121–129. 2013. View Article : Google Scholar : PubMed/NCBI
24	Ye X, Guo Y, Zhang Q, et al: βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/cyclin D1 signaling pathway. PLoS One. 8:e556152013.
25	Xie B, Zhou J, Shu G, et al: Restoration of klotho gene expression induces apoptosis and autophagy in gastric cancer cells: tumor suppressive role of klotho in gastric cancer. Cancer Cell Int. 13:182013. View Article : Google Scholar : PubMed/NCBI
26	Chen L, Liu H, Liu J, et al: Klotho endows hepatoma cells with resistance to anoikis via VEGFR2/PAK1 activation in hepatocellular carcinoma. PLoS One. 8:e584132013. View Article : Google Scholar : PubMed/NCBI
27	Zhu Y, Xu L, Zhang J, et al: Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma. Cancer Sci. 104:663–671. 2013.PubMed/NCBI
28	Wang Y, Chen L, Huang G, et al: Klotho sensitizes human lung cancer cell line to cisplatin via PI3k/Akt pathway. PLoS One. 8:e573912013. View Article : Google Scholar : PubMed/NCBI
29	do Lim Y, Cho HJ, Kim J, et al: Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. BMC Gastroenterol. 12:92012.PubMed/NCBI
30	Risio M: Cell proliferation in colorectal tumor progression: an immunohistochemical approach to intermediate biomarkers. J Cell Biochem (Suppl). 16G:79–87. 1992. View Article : Google Scholar : PubMed/NCBI
31	Liabakk NB, Talbot I, Smith RA, et al: Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res. 56:190–196. 1996.
32	Fu Y, Zhang Q, Kang C, et al: Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Cancer Biol Ther. 8:1002–1009. 2009. View Article : Google Scholar